N
Patient 1
| Seq | Brand | Generic | Manufacturer | Product code | Model | Catalog | Lot | PMA | 510(k) | Implant | Evaluated | Availability |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TRIGB TRIGLYCERIDES/GLYCEROL BLANKED | LIPASE HYDROLYSIS/GLYCEROL KINASE ENZYME, TRIGLYCERIDES | ROCHE DIAGNOSTICS | CDT | NA | 05976006190 | ASKU | R | Y |
| Sequence | Received | Treatment | Outcome |
|---|---|---|---|
| 1 | 2018-09-21 | 0 |
Patient 1
Patient 1
THE CUSTOMER COMPLAINED OF LOW DISCREPANT RESULTS FOR 3 PATIENT SAMPLES TESTED FOR TRIGB TRIGLYCERIDES/GLYCEROL BLANKED (TRIGB) ON A COBAS 8000 C 702 MODULE. PATIENT 1 INITIAL TRIGB RESULT WAS 319 MG/DL. THIS RESULT WAS REPORTED OUTSIDE OF THE LABORATORY WHERE IT WAS QUESTIONED BY THE DOCTOR. ON (B)(6) 2018 THE SAMPLE WAS REPEATED AND THE RESULT WAS 232 MG/DL WITH A DATA FLAG. THE SAMPLE WAS REPEATED WITH AUTO-DILUTION AND THE RESULT WAS 4121 MG/DL. ON (B)(6) 2018 PATIENT 2 (FEMALE, (B)(6)) INITIAL TRIGB RESULT WAS 558 MG/DL. THIS RESULT WAS REPORTED OUTSIDE OF THE LABORATORY WHERE IT WAS QUESTIONED BY THE DOCTOR. ON (B)(6) 2018 THE SAMPLE WAS REPEATED AND THE RESULT WAS 514 MG/DL WITH A DATA FLAG. THE SAMPLE WAS REPEATED WITH AUTO-DILUTION AND THE RESULT WAS 3511 MG/DL. ON (B)(6) 2018 PATIENT 3 (FEMALE, (B)(6)) INITIAL TRIGB RESULT WAS 681 MG/DL. THIS RESULT WAS REPORTED OUTSIDE OF THE LABORATORY WHERE IT WAS QUESTIONED BY THE DOCTOR. THE SAMPLE WAS REPEATED WITH AUTO-DILUTION AND THE RESULT WAS 3337 MG/DL. THE REPEAT RESULTS USING AUTO-DILUTION WERE BELIEVED TO BE CORRECT. NO ADVERSE EVENT OCCURRED. THE C702 MODULE SERIAL NUMBER WAS (B)(4). THE FIELD SERVICE ENGINEER (FSE) VISITED THE CUSTOMER SITE AND FOUND THE SYSTEM WAS OPERATING NORMALLY AND THERE WAS NO ISSUE WITH THE C702 MODULE. THE CUSTOMER HAS NOT HAD ANY FURTHER EVENTS. THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM. THE CAUSE OF THE EVENT COULD NOT BE DETERMINED.